AbbVie ROI - Return on Investment 2010-2025 | ABBV

AbbVie return on investment for the quarter ending March 31, 2025 was 8.6.

  • AbbVie average return on investment for 2024 was 7.71, a 18.59% increase from 2023.
  • AbbVie average return on investment for 2023 was 9.47, a 39.99% decline from 2022.
  • AbbVie average return on investment for 2022 was 15.78, a 80.76% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

AbbVie ROI - Return on Investment 2010-2025 | ABBV

  • AbbVie average return on investment for 2024 was 7.71, a 18.59% increase from 2023.
  • AbbVie average return on investment for 2023 was 9.47, a 39.99% decline from 2022.
  • AbbVie average return on investment for 2022 was 15.78, a 80.76% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.